DOCSLIB.ORG

The Anatolian Journal of Cardiology®

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Anatolian Journal of Cardiology® ® The Anatolian Journal of Cardiology Anatol J Cardiol, Vol: 20, (Suppl 1), October 2018 Editor-in-Chief Prof. Dr. Çetin Erol, Ankara, Turkey Editor Mustafa Kılıçkap, Ankara, Turkey Associate Editors Adnan Abacı, Ankara, Turkey Kurtuluş Özdemir, Konya, Turkey Rüçhan Akar, Ankara, Turkey Murat Özeren, Mersin, Turkey Bülent Behlül Altunkeser, Konya, Turkey Leyla Elif Sade, Ankara, Turkey Ahmet Kaya Bilge, İstanbul, Turkey Asife Şahinarslan, Ankara, Turkey Hakim Çelik, Şanlıurfa, Turkey Ahmet Temizhan, Ankara, Turkey Recep Demirbağ, Şanlıurfa, Turkey Ercan Tutar, Ankara, Turkey Ş. Remzi Erdem, Ankara, Turkey Omaç Tüfekçioğlu, Ankara, Turkey İlkay Erdoğan, Ankara, Turkey F. Ajlan Tükün, Ankara, Turkey Sadi Güleç, Ankara, Turkey Taner Ulus, Eskişehir, Turkey Ali Gürbüz, İzmir, Turkey Aylin Yıldırır, Ankara, Turkey Serdar Kula, Ankara, Turkey Mehmet Birhan Yılmaz, Sivas, Turkey Selma Metintaş, Eskişehir, Turkey Editor-in-Chief Consultant Senior Consultant in Biostatistics Consultant in Biostatistics Suna Kıraç, Lefkoşe, KKTC Kazım Özdamar, Eskişehir, Turkey Fezan Mutlu, Eskişehir, Turkey Previous Editor-in-Chief Bilgin Timuralp, Eskişehir, Turkey Editorial Board Ramazan Akdemir, Sakarya, Turkey Ertuğrul Ercan, İzmir, Turkey Serdar Küçükoğlu, İstanbul, Turkey Shahbudin Rahimtoola, Los Angeles, CA, USA Levent Akyürek, Göteborg, Sweden Okan Erdoğan, İstanbul, Turkey Peter Macfarlane, Renfrewshire, Scotland Vedat Sansoy, İstanbul, Turkey Azin Alizadehasl, Tehran, Iran Özcan Erel, Ankara, Turkey Robert W. Mahley, San Francisco, CA, USA Raşit Sayın, Trabzon, Turkey Necmi Ata, Eskişehir, Turkey Ali Gholamrezanezhad, Tahran, İran Giuseppe Mancia, Milan, Italy Mark V. Sherrid, New York, USA Saide Aytekin, İstanbul, Turkey Michael Gibson, Boston, MA, USA G.B. John Mancini, Vancouver BC, Canada Horst Sievert, Frankfurt, Germany Vedat Aytekin, İstanbul, Turkey Orhan Gökalp, İzmir, Turkey Anthony De Maria, San Diego, CA, USA İlke Sipahi, İstanbul, Turkey Ljuba Bacharova, Bratislava, Slovak Republic Bülent Görenek, Eskişehir, Turkey Pascal Meier, London, UK Richard Sutton, Monaco, Monaco Ahmet Şaşmazel, İstanbul, Turkey Luiggi P. Badano, Udine, Italy Okan Gülel, Samsun, Turkey Franz H. Messerli, New York, USA S. Lale Tokgözoğlu, Ankara, Turkey Anzel Bahadır, Düzce, Turkey Sema Güneri, İzmir, Turkey Sanem Nalbantgil, İzmir, Turkey Murat Tuzcu, Cleveland, OH, USA Adrian Baranchuk, Kingston, Ontario, Canada Yekta Gürlertop, Edirne, Turkey Navin C. Nanda, Birmingham, AL, USA Dilek Ural, İstanbul, Turkey Murat Biteker, Muğla, Turkey Murat Güvener, Ankara, Turkey Yılmaz Nişancı, İstanbul, Turkey Ahmet Ünalır, Eskişehir, Turkey Eugene Braunwald, Boston, MA, USA Cemil İzgi, London, UK Hakan Oral, Ann Arbor, MI, USA Selma Arzu Vardar, Edirne, Turkey Cahid Civelek, St. Louis, MO, USA Diwakar Jain, Philadelphia, USA Necla Özer, Ankara, Turkey Mehmet Yokuşoğlu, Ankara, Turkey Ali Emin Denktaş, Houston, TX, USA Erdem Kaşıkçıoğlu, İstanbul, Turkey Zeki Öngen, İstanbul, Turkey Jose L. Zamorano, Madrid, Spain Polychronis Dilaveris, Athens, Greece Cihangir Kaymaz, İstanbul, Turkey Mehmet Özkan, İstanbul, Turkey Wojciech Zareba, New York, USA Fırat Duru, Zurich, Switzerland Mustafa Kılıç, Denizli, Turkey Sotirios N. Prapas, Athens, Greece Yuqing Zhang, Beijing, China Editor-in-Chief Office Phone : +90 (535) 461 41 62 Fax : +90 (212) 221 17 54 KARE E-mail : [email protected] The Owner on behalf of Publisher: Kare Yayıncılık (Kare Publishing) the Turkish Society of Cardiology Assistants to the Editor-in-Chief Concord İstanbul Dumlupınar Mah. Yumurtacı Abdi Bey Ebru BOZ Cad. Cihan Sok. No: 15, B Blok Da: 162 Kat: 21, Kadıköy, Türk Kardiyoloji Derneği adına Elif SÖNMEZ İmtiyaz Sahibi İstanbul, TURKEY Mustafa Kemal EROL Phone: +90 216 550 61 11 Address : Nish İstanbul A Blok Kat: 8, No: 47-48 Fax: +90 216 550 61 12 Çobançeşme Sanayi Cad. No: 11 http://www.kareyayincilik.com Yenibosna, Bahçelievler 34196 İstanbul, Türkiye E-mail: [email protected] Phone : +90 212 221 1730-38 Fax : +90 212 221 1754 E-mail : [email protected] Web : www.tkd.org.tr th TURKISH CARDIOLOGY CONGRESS 34 WITH INTERNATIONAL PARTICIPATION THE EXECUTIVE BOARD OF TURKISH SOCIETY OF CARDIOLOGY President Mustafa Kemal EROL President Elect Vedat AYTEKİN Vice President Muzaffer DEĞERTEKİN Secretary General Cevat KIRMA Secretary Sami ÖZGÜL Treasurer Ertuğrul OKUYAN Members Bülent GÖRENEK Bülent MUTLU Asiye Ayça BOYACI CONGRESS SCIENTIFIC COMMITTEE Vedat AYTEKİN, President Armağan ALTUN Asiye Ayça BOYACI Bülent GÖRENEK Hakan KÜLTÜRSAY Ender ÖRNEK Halil İbrahim TANBOĞA Dursun ARAS Neşe ÇAM Sadi GÜLEÇ Bülent MUTLU Nihal ÖZDEMİR İstemihan TENGİZ Özgür ASLAN Yüksel ÇAVUŞOĞLU Sema GÜNERİ Sanem NALBANTGİL Filiz Özerkan ÇAKAN Selim TOPÇU Saide AYTEKİN Muzaffer DEĞERTEKİN Aziz KARABULUT Ertuğrul OKUYAN Sami ÖZGÜL Eralp TUTAR Mehmet BALLI İrem DİNÇER Cevat KIRMA Alper ONBAŞILI Leyla Elif SADE Oğuz YAVUZGIL İbrahim BAŞARICI Okan ERDOĞAN Zeki ÖNGEN Vedat SANSOY INTERNATIONAL SCIENTIFIC COMMITTEE MEMBERS Farid ALIYEV President, Azerbaijan Cardiology Society Nurlan ABDIKALIYEV President, Kazakhistan Cardiology Society Gani BAJRAKTARI President, Kosovo Cardiology Society Firdovsi İBRAHIMOV President, Turkic World Cardiology Cardiology Society Zumreta KUSLJUGIC President, Bosnia Hersegovina Cardiology Society Erkin MIRRAKHIMOV President, Kırgızistan Cardiology Society RESEARCH AND PROJECT GROUP PRESIDENTS İlyas ATAR Arrhythmia Working Group President Enver ATALAR Association of Percutaneous Cardiovascular Interventions President Atila BITIGEN Hypertension Working Group President Öner ÖZDOĞAN Lipid Working Group President Hakan ALTAY Heart Failure Working Group President Mustafa ÇALIŞKAN Coronary Heart Disease Working Group President Levent KORKMAZ Heart Valve Diseases Working Group President Bülent MUTLU Pulmonary Vascular and Mature Congenital Cardiac Diseases W.G. President Ebru ÖZPELIT Cardiac Imaging Working Group President Ahmet KARA Nursing and Technician Project Group President th TURKISH CARDIOLOGY CONGRESS 34 WITH INTERNATIONAL PARTICIPATION Dear Colleagues, In addition to its various training events and activities through the year, Turkish Society of Cardiology has planned to hold this year’s National Cardiology Congress in October at a high level to meet the expectations on its 54th anniversary. The congress, as a leading scientific event both at the national and international level with a remarkable number of participants and high quality scientific content, is being designed to appeal to all participants in a satisfactory way and broad range of its scientific program and diversified flavors of social events. As well as our colleagues as members of European Society of Cardiology, there will be again our colleagues from different continents as participants to this year’s congress. We expect to have a higher number of participation to this year’s congress in which the number of participation was nearly 3000 last year. We have been working hard to prepare the best program for you. During our "Symposia", "Debates" and "How to Do" sessions, we will be updating our latest knowledge on cardiovascular diseases. We have extended “Cardiology in Daily Practice” sessions which attracted real attention last year, as “Practical Cardiology” to cover all the practices in Cardiology. We will advance our skills besides our knowledge thanks to “Interactive Video Courses” which we have increased the number in line with the high attention paid during the recent years and a certificate is provided to the participants of the courses. Every session will take place with participation of esteemed speakers and discussants from Turkey and from around the globe. We strongly believe that our joint sessions with the ESC, ACC, Turkic World Cardiology Association, EHRA and EAPCI will be closely followed by the attendees. The congress having strengthened more than ever with its international flavor will again be credited by the Turkish Medical Association and EBAC. We will be more than happy to have you with us during our congress. With hopes and best regards to meet you and share our information on 05 – 08 October 2017 for the occasion of our 33th Turkish Cardiology Congress with International Participation. Respectfully, Prof. Mustafa Kemal Erol, M.D. Prof. Vedat Aytekin, M.D. President of TSC President Elect of TSC th TURKISH CARDIOLOGY CONGRESS 34 WITH INTERNATIONAL PARTICIPATION CONTENTS ORAL PRESENTATIONS ..............................................................1 POSTER PRESENTATIONS ........................................................75 AUTHOR INDEX ........................................................................147 The abstracts are being reprinted without Journal editorial review. The opinions expressed in this supplement are those of the panelists and are not attributable to the sponsor or the publisher, editor, or editorial board of the Anatolian Journal of Cardiology. Clinical judgment must guide each physican in weighing the benefits of treatment against the risk of toxicity. References made in the articles may indicate uses of drugs at dosages, for periods of time, and in combinations not included in the current prescribing information. TSC Abstracts/ORALS Anatol J Cardiol 2018; 20 (Suppl 1): 1-155 October 20-23, 2018 1 Arrhythmia / Electrophysiology / Pacemaker / CRT- ICD with low LVEF. However, there are no studies investigating the prospective value of TWA in patients with young ST-elevated myocardial infarction (STEMI) patients with preserved LVEF. The aim of this study is to determine the
Load more

Recommended publications
  • Stent Technology Takes Two Steps Forward
    Inside This Issue Heart and Vascular Update Hybrid operating room, provides information to PRESORTED HEART and VASCULAR healthcare providers on the latest FIRST CLASS MAIL a regional first in cardiovascular medicine and surgery U.S. POSTAGE at The Christ Hospital. PAID Stent technology takes CINCINNATI, OH Heart and Vascular Update PERMIT #5489 two steps forward Editorial Board 2139 Auburn Avenue | Cincinnati, Ohio 45219 Stent technology Dean J. Kereiakes, MD, FDA advisory panel: Medical Director SPRING 2013 The Christ Hospital Heart and Vascular Center Update MitraClip could serve as takes two steps forward Carl and Edyth Lindner Research Center an alternative treatment Ian Sarembock, MD, Executive Medical Director for reducing mitral Resorbable Absorb scaffold and flexible Absorb takes bioabsorbability to next level The Christ Hospital Heart and Vascular Service Line regurgitation For the past two decades, incremental improvements in stent Mike Keating Synergy stent expected to improve technology have improved outcomes for hundreds of thousands of President and CEO outcomes in coronary artery disease people with coronary artery blockages. These devices have evolved Michael W. Schwebler from short, bare-metal mesh tubes that could be deployed only The Carl and Eydth Lindner Research Center at The Christ Hospital is Executive Director in the largest coronary vessels to a variety of thinner, longer stents The Christ Hospital Heart and Vascular Service Line leading two major clinical trials that will significantly advance stent coated with
    [Show full text]
  • Program PDF Saturday, March 28, 2020 Updated: 02-14-20
    Program PDF Saturday, March 28, 2020 Updated: 02-14-20 Special ‐ Events and Meetings Congenital Heart Disease ‐ Scientific Session #5002 Session #602 Fellowship Administrators in Cardiovascular Education and ACHD Cases That Stumped Me Training Meeting, Day 2 Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. Saturday, March 28, 2020, 7:30 a.m. ‐ 5:30 p.m. Room S105b Marriott Marquis Chicago, Great Lakes Ballroom A CME Hours: 1.5 / CNE Hours: CME Hours: / CNE Hours: Co‐Chair: C. Huie Lin 7:30 a.m. Co‐Chair: Karen K. Stout Fellowship Administrators in Cardiovascular Education and Training Meeting, Day 2 8:00 a.m. LTGA, Severe AV Valve Regurgitation, Moderately Reduced EF, And Atrial Acute and Stable Ischemic Heart Disease ‐ Scientific Arrhythmia Session #601 Elizabeth Grier Treating Patients With STEMI: What They Didn't Teach You in Dallas, TX Fellowship! Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. 8:05 a.m. Room S505a ARS Questions (Pre‐Panel Discussion) CME Hours: 1.5 / CNE Hours: Elizabeth Grier Dallas, TX Co‐Chair: Frederick G. Kushner Co‐Chair: Alexandra J. Lansky 8:07 a.m. Panelist: Alvaro Avezum Panel Discussion: LTGA With AVVR And Reduced EF Panelist: William W. O'Neill Panelist: Jennifer Tremmel Panelist: Jonathan Nathan Menachem Panelist: Joseph A. Dearani 8:00 a.m. Panelist: Michelle Gurvitz Case of a Young Women With STEMI Panelist: David Bradley Jasjit Bhinder Valhalla, NY 8:27 a.m. ARS Questions (Post‐Panel Discussion) 8:05 a.m. Elizabeth Grier Young Women With STEMI: Something Doesn't Make Sense...
    [Show full text]
  • Surgical Management of Transcatheter Heart Valves
    Corporate Medical Policy Surgical Management of Transcatheter Heart Valves File Name: surgica l_management_of_transcatheter_heart_valves Origination: 1/2011 Last CAP Review: 6/2021 Next CAP Review: 6/2022 Last Review: 6/2021 Description of Procedure or Service As the proportion of older adults increases in the U.S. population, the incidence of degenerative heart valve disease also increases. Aortic stenosis and mitra l regurgita tion are the most common valvular disorders in adults aged 70 years and older. For patients with severe valve disease, heart valve repair or replacement involving open heart surgery can improve functional status and qua lity of life. A variety of conventional mechanical and bioprosthetic heart valves are readily available. However, some individuals, due to advanced age or co-morbidities, are considered too high risk for open heart surgery. Alternatives to the open heart approach to heart valve replacement are currently being explored. Transcatheter heart valve replacement and repair are relatively new interventional procedures involving the insertion of an artificial heart valve or repair device using a catheter, rather than through open heart surgery, or surgical valve replacement (SAVR). The point of entry is typically either the femoral vein (antegrade) or femora l artery (retrograde), or directly through the myocardium via the apical region of the heart. For pulmonic and aortic valve replacement surgery, an expandable prosthetic heart valve is crimped onto a catheter and then delivered and deployed at the site of the diseased native valve. For valve repair, a small device is delivered by catheter to the mitral valve where the faulty leaflets are clipped together to reduce regurgitation.
    [Show full text]
  • Highlights from the Latest Articles in Ablation and Endovascular Valve Repair
    NEWS & VIEWS Research Highlights Highlights from the latest articles in ablation and endovascular valve repair Torsten Konrad*1 Relationship between electrical & Thomas Rostock1 1II Medical Clinic, Department of Electrophysiology, University Medical Center, Johannes pulmonary vein reconnection and Gutenberg-University Mainz, Langenbeckstraße 1, D-55131 Mainz, Germany *Author for correspondence: Tel.: +49 613 117 7218 contact force during initial pulmonary Fax: +49 613 117 5534 [email protected] vein isolation Financial & competing interests disclosure All PVs were initially successfully isolated The authors have no relevant affiliations or financial Evaluation of: Neuzil P, Reddy V, with this technique. In almost half of the involvement with any organization or entity with a Kautzner J et al. Electrical patients, a deflectable sheath was used financial interest in or financial conflict with the reconnection after pulmonary vein during the initial ablation procedure subject matter or materials discussed in the manu- isolation is contingent on contact (mean CF was not different when using script. This includes employment, consultancies, force during initial treatment: a deflectable or conventional sheath). honoraria, stock ownership or options, expert testi- results from the EFFICAS I study. In general, CF was higher in the right mony, grants or patents received or pending, or Circ. Arrhythm. Electrophysiol. 6, PVs than the left PVs. Lowest CFs were royalties. 327–333 (2013). observed during ablation of the left PVs No writing assistance was utilized in the at the anterior superior and anterior infe- production of this manuscript. Pulmonary vein (PV) isolation is the rior aspect of the PVs. The highest CFs most common and effective interven- were documented at the anterior inferior tional treatment for paroxysmal atrial aspect of the right PVs.
    [Show full text]
  • Development of a Simultaneous Cryo-Anchoring and Radiofrequency Ablation Catheter for Percutaneous Treatment of Mitral Valve Prolapse
    DEVELOPMENT OF A SIMULTANEOUS CRYO-ANCHORING AND RADIOFREQUENCY ABLATION CATHETER FOR PERCUTANEOUS TREATMENT OF MITRAL VALVE PROLAPSE By Steven Michael Boronyak Thesis Submitted to the Faculty of the Graduate School of Vanderbilt University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE in Biomedical Engineering May, 2012 Nashville, Tennessee Approved: W. David Merryman, Ph.D. Robert L. Galloway, Ph.D. ACKNOWLEDGEMENTS First, I would like to thank Dr. David Merryman for his guidance and support throughout the last two years. Second, I would like to thank my fellow lab members for making work more fun than it needs to be. Third, this work was funded by the Wallace H. Coulter Foundation, and I thank them, too. Cheers. ii TABLE OF CONTENTS Page ACKNOWLEDGEMENTS ................................................................................................ ii LIST OF FIGURES .......................................................................................................... v I. INTRODUCTION ......................................................................................................... 1 Background.......................................................................................................... 1 Mitral Valve Anatomy and Function ......................................................... 1 Mitral Regurgitation and Mitral Valve Prolapse ........................................ 2 MVP Due to Degenerative MR ................................................................ 3 Repair of the
    [Show full text]
  • Download Des Gedruckten Programms (PDF
    79. Jahrestagung der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. 79th Annual Meeting of the German Cardiac Society Die Kardiomyopathien The Cardiomyopathies Tagungspräsident / President of the Congress Prof. Dr. Hugo A. Katus, Heidelberg Präsident der Gesellschaft / President of the Society Prof. Dr. Georg Ertl, Würzburg Geschäftsführer der Gesellschaft / Managing Director Dipl.-Math. Konstantinos Papoutsis, Düsseldorf Änderungen vorbehalten. Aktualisierungen nach Drucklegung aufrufbar unter: http://ft2013.dgk.org Drucklegung: 20.02.2013 Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. 79. Jahrestagung 2013, Mannheim Vorwort • Vorstand • Kommissionen 6 - 9 Projekt- und Arbeitsgruppen • Arbeitsgemeinschaften 10 - 16 Ehrungen und Preise 18 Stipendien und Preise 19 - 20 Poster- und Abstractpreise 21 Sonstige Preise 21 Tagungsort/Öffnungszeiten • Allgemeine Informationen 22 - 27 Hinweise für Referenten • Hinweise für Posterreferenten 28 - 31 Ankündigungen • Weiter- und Fortbildungs-Akademie „Kardiologie“ 32 - 40 Mittwoch, 3. April 2013 Raumplan - Wissenschaftliches Programm 42 - 111 Donnerstag, 4. April 2013, vormittags Raumplan - Wissenschaftliches Programm 114 - 188 Donnerstag, 4. April 2013, nachmittags Wissenschaftliches Programm 190 - 255 Freitag, 5. April 2013, vormittags Raumplan - Wissenschaftliches Programm 258 - 338 Freitag, 5. April 2013, nachmittags Wissenschaftliches Programm 340 - 398 Samstag, 6. April 2013, vormittags Raumplan - Wissenschaftliches Programm 400 - 465 Samstag,
    [Show full text]
  • Selecting Candidates for Transcatheter Mitral Valve Repair
    • INNOVATIONS Key Points Selecting Candidates for • Mitral valve regurgitation, or leaky mitral valve, is a common valve disorder Transcatheter Mitral Valve Repair in which the leaflets of the mitral valve fail to seal effectively, resulting in Annapoorna S. Kini, MD Samin K. Sharma, MD some blood flowing back in the left atrium every time Mitral valve regurgitation is a common valve disorder The EVEREST (Endovascular Valve Edge-to- the left ventricle contracts. that causes blood to leak backward through the Edge Repair Study) II Trial was a randomized study This condition has been mitral valve and into the left atrium as the heart comparing the transcatheter approach using traditionally addressed muscle contracts. Mitral regurgitation can originate MitraClip®—a tiny cobalt chromium clip that sutures with open heart surgery. from degenerative or structural defects due to the anterior and posterior mitral valve leaflets—with aging, infection, or congenital anomalies. In contrast, surgery in patients with moderate to severe mitral • We use the latest imaging functional mitral regurgitation occurs when coronary regurgitation who are candidates for either procedure. techniques both to ensure artery disease or events such as a heart attack change that each patient is a good After five years, the study has demonstrated that the size and shape of the heart muscle, preventing candidate for the procedure, MitraClip was associated with a similar risk of death the mitral valve from opening and closing properly. In and to monitor their progress compared with mitral valve surgery after excluding people with moderate to severe mitral regurgitation, once the device is implanted. patients who required surgery within six months.
    [Show full text]
  • Medicare National Coverage Determinations Manual, Part 1
    Medicare National Coverage Determinations Manual Chapter 1, Part 1 (Sections 10 – 80.12) Coverage Determinations Table of Contents (Rev. 10838, 06-08-21) Transmittals for Chapter 1, Part 1 Foreword - Purpose for National Coverage Determinations (NCD) Manual 10 - Anesthesia and Pain Management 10.1 - Use of Visual Tests Prior to and General Anesthesia During Cataract Surgery 10.2 - Transcutaneous Electrical Nerve Stimulation (TENS) for Acute Post- Operative Pain 10.3 - Inpatient Hospital Pain Rehabilitation Programs 10.4 - Outpatient Hospital Pain Rehabilitation Programs 10.5 - Autogenous Epidural Blood Graft 10.6 - Anesthesia in Cardiac Pacemaker Surgery 20 - Cardiovascular System 20.1 - Vertebral Artery Surgery 20.2 - Extracranial - Intracranial (EC-IC) Arterial Bypass Surgery 20.3 - Thoracic Duct Drainage (TDD) in Renal Transplants 20.4 – Implantable Cardioverter Defibrillators (ICDs) 20.5 - Extracorporeal Immunoadsorption (ECI) Using Protein A Columns 20.6 - Transmyocardial Revascularization (TMR) 20.7 - Percutaneous Transluminal Angioplasty (PTA) (Various Effective Dates Below) 20.8 - Cardiac Pacemakers (Various Effective Dates Below) 20.8.1 - Cardiac Pacemaker Evaluation Services 20.8.1.1 - Transtelephonic Monitoring of Cardiac Pacemakers 20.8.2 - Self-Contained Pacemaker Monitors 20.8.3 – Single Chamber and Dual Chamber Permanent Cardiac Pacemakers 20.8.4 Leadless Pacemakers 20.9 - Artificial Hearts And Related Devices – (Various Effective Dates Below) 20.9.1 - Ventricular Assist Devices (Various Effective Dates Below) 20.10 - Cardiac
    [Show full text]
  • Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy—Current Evidence and Practice
    Published online: 2019-08-17 1590 Theme Issue Article Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy—Current Evidence and Practice Tobias Geisler1 Rezo Jorbenadze1 Aron-Frederik Popov2 Karin L. Mueller1 Dominik Rath1 Michal Droppa1 Juergen Schreieck1 Peter Seizer1 Robert F. Storey3 Steen D. Kristensen4 Andrea Rubboli5 Diana Gorog6,7 Daniel Aradi8,9 Dirk Sibbing10,11 Kurt Huber12,13 Meinrad Gawaz1 Jur Ten Berg14 1 Department of Cardiology and Angiology, University Hospital, Address for correspondence Tobias Geisler, MD, MHBA, Department Eberhard-Karls University of Tübingen, Tübingen, Germany of Cardiology and Angiology, University Hospital, Eberhard-Karls 2 Department of Thoracic and Cardiovascular Surgery, University University of Tübingen, Tübingen, Germany Medical Center Tübingen, Eberhard-Karls University of Tübingen, (e-mail: [email protected]; [email protected]). Tübingen, Germany 3 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom 10Department of Cardiology, LMU München, Munich, Germany 4 Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark 11DZHK (German Centre for Cardiovascular Research), partner site 5 Division of Cardiology, Department of Cardiovascular Disease– Munich Heart Alliance, Munich, Germany AUSL Romagna, Ospedale S. Maria delle Croci, Ravenna, Italy 123rd Department of Medicine, Cardiology and Intensive Care 6 National Heart and Lung Institute, Imperial College London, Medicine, Wilhelminenhospital, Vienna, Austria London, United Kingdom 13Medical Faculty, Sigmund Freud University, Vienna, Austria 7 University of Hertfordshire, Hertfordshire, United Kingdom 14Department of Cardiology, St Antonius Hospital, Nieuwegein, 8 Heart Center Balatonfured, Balatonfured, Hungary The Netherlands 9 Heart and Vascular Center, Semmelweis University, Budapest, Hungary Thromb Haemost 2019;119:1590–1605.
    [Show full text]
  • Review of Diagnostic and Therapeutic Approach to Canine Myxomatous Mitral Valve Disease
    veterinary sciences Review Review of Diagnostic and Therapeutic Approach to Canine Myxomatous Mitral Valve Disease Giulio Menciotti * ID and Michele Borgarelli Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, 205 Duck Pond Dr., Blacksburg, VA 24061, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-540-2314-621 Academic Editors: Sonja Fonfara and Lynne O’Sullivan Received: 23 June 2017; Accepted: 20 September 2017; Published: 26 September 2017 Abstract: The most common heart disease that affects dogs is myxomatous mitral valve disease. In this article, we review the current diagnostic and therapeutic approaches to this disease, and we also present some of the latest technological advancements in this field. Keywords: dogs; heart; echocardiography; mitral repair 1. Introduction Among canine cardiac diseases, myxomatous mitral valve disease (MMVD) represents, by far, the most common. In general, the disease is more prevalent in small breeds than in large breeds, and some small breeds are reported to have an incidence close to 100% over a dog’s lifetime [1,2]. However, large breed dogs can be affected as well [3,4]. A heritable, genetically-determined component for the disease can be implied by the strong predilection for small breeds in general, and particularly for certain breeds (i.e., Cavalier King Charles Spaniels, Dachshund), in which the heritability of disease status and severity has been demonstrated [5–7]. However, the etiology of the myxomatous process is still unknown and under investigation. Some experimental evidence seems to support a possible role of the serotonin signaling pathway triggered by altered mechanical stimuli in the disease development [8–12].
    [Show full text]
  • Mitraclip Cases
    MitraClip Cases Sunil Mankad, MD, FACC, FCCP, FASE Associate Professor of Medicine Mayo Clinic College of Medicine Director, Transesophageal Echocardiography Associate Director, Cardiology Fellowship Mayo Clinic, Rochester, MN ACC Governor, Minnesota [email protected] @MDMankad DISCLOSURE Relevant Financial Relationship(s) None Off Label Usage None Case 1 • 86 year old female • Acute onset dyspnea from pulmonary edema • History of prior CABG • CKD (creatinine 2.0 mg/dl) • Paroxysmal atrial fibrillation • Physical exam – 3/6 holosystolic murmur • TTE – Flail MV with severe mitral regurgitation – LV EF 60% CXR EKG • Catheterization: Patent Grafts TEE TEE: Flail MV Posterior Leaflet A1-P1/lateral portion of P2 TEE A2-medial portion P2 A3-P3 TEE: Commissural View TEE TEE 3D TEE: View from LA Mitral Valve • Mean Gradient 5 mmHg at HR of 88 BPM • Valve area >4.0 cm2 Heart Team Discussion • CV Surgery, Valve/Imaging Specialist, and Structural Interventionalist → Decision made to proceed with MitraClip Procedural TEE: Flail P2 (Lateral Portion) Transeptal Puncture Sheath in Left Atrium MitraClip Device in Left Atrium MitraClip Device Toward MV Heading Toward Valve Importance of Clip Orientation Wrong Correct Grasping MV MV Grasped MV Grasped Final Result: Mild MR Mean Gradient 5 at HR 77 BPM Final 3D Images 45 mmHg Pre-clip Post-clip 15 mmHg Left Atrial “V” wave Tracings Atrial Septum: Small ASD Pre-discharge TTE: Mild MR → Mean Gradient 3 at HR 59 BPM Outcome • Patient discharged home 4 days post- procedure • Dyspnea markedly improved • Continues
    [Show full text]
  • Mitral Valve Disease
    ©2010 David Stultz, MD MitralMitral valvevalve diseasedisease DavidDavid Stultz,Stultz, MD,MD, FACCFACC SouthwestSouthwest Cardiology,Cardiology, Inc.Inc. SeptemberSeptember 28,28, 20102010 ©2010 David Stultz, MD ObjectivesObjectives IdentifyIdentify thethe principleprinciple causecause ofof mitralmitral stenosisstenosis NameName severalseveral mechanismsmechanisms ofof mitralmitral regurgitationregurgitation IdentifyIdentify howhow oftenoften mitralmitral regurgitationregurgitation shouldshould bebe followedfollowed byby echocardiogramechocardiogram ©2010 David Stultz, MD ThisThis ConferenceConference isis anan OverviewOverview ManyMany aspectsaspects cannotcannot bebe coveredcovered inin aa 11 hourhour conferenceconference ThisThis isis meantmeant toto serveserve asas aa frameworkframework forfor furtherfurther knowledgeknowledge ©2010 David Stultz, MD OutlineOutline ofof conferenceconference MitralMitral StenosisStenosis MitralMitral regurgitationregurgitation MitralMitral valvevalve prolapseprolapse SurgicalSurgical andand endovascularendovascular repairrepair ©2010 David Stultz, MD Libby P, Bonow RO, Mann DL, Zipes DP. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Saunders, 2007. ©2010 David Stultz, MD SurgicalSurgical AnatomyAnatomy Fedak PW, McCarthy PM, Bonow RO. Evolving concepts and technologies in mitral valve repair. Circulation. 2008 Feb 19;117(7):963- 74. ©2010 David Stultz, MD MitralMitral StenosisStenosis NarrowingNarrowing ofof thethe mitralmitral valvevalve orificeorifice RestrictsRestricts
    [Show full text]